J. Aaseth et al., HEPATIC RETENTION OF COPPER AND SELENIUM IN PRIMARY SCLEROSING CHOLANGITIS, Scandinavian journal of gastroenterology, 30(12), 1995, pp. 1200-1203
Background: Previous studies have suggested abnormal copper metabolism
in patients with primary sclerosing cholangitis (PSC). In the present
work the trace element metabolism was studied in a group of 32 patien
ts with PSC. Methods: Hepatic copper and selenium concentrations were
determined with a sensitive electrothermal atomic absorption technique
. Serum concentrations of copper and zinc were determined by conventio
nal atomic absorption. Results: For the patient group serum copper val
ues (20.3 +/- 4.5 mu mol/l) were higher than those for the control gro
up (14 +/- 3 mu mol/l), and average hepatic copper concentrations were
greater by a factor of four. Serum selenium values were slightly lowe
r, although the average hepatic selenium was significantly higher than
in the healthy control group. Previous studies have discussed possibl
e toxic effects of hepatocellular copper accumulation, which may be ac
companied by formation of activated oxygen species and depletion of gl
utathione. In the present study, however, it could nor be demonstrated
that the concentration of the lipoperoxidation product, malonic diald
ehyde, was higher than normal in blood. Furthermore, blood concentrati
ons of glutathione and glutathione peroxidase were not abnormal. Concl
usion: Although a protective effect of the raised selenium concentrati
ons in the liver might be discussed, it is apparent that the copper ac
cumulation in the liver cells described here did not induce detectable
changes in the indices studied.